Resources

The Smoke-Free UK Project


The tobacco epidemic is one of the biggest public health threats the world has ever faced, killing more than 8 million people a year around the world. The UK has been at the forefront of initiating many forward-thinking policies for helping smokers quit, and is one few countries who have successfully brought the adult smoking rates down to 14.1% (2019). It is great to see Public Health England and other national health authorities supporting Tobacco Harm Reduction (THR) tools, along with behavioural therapy and other licenced medications, in order to provide more choice of cessation products, to help smokers quit smoking.


In July 2019, the UK Government set out its ambition for England to be “smokefree by 2030”. Despite being the world leader in forward thinking tobacco control policies and having a range of smoking cessation tools available with free support, we are seeing that the decrease in smoking prevalence in the UK is plateauing. Also some specific subgroups of the population have higher smoking rates than the national average. E.g. while a decrease in smoking rates has also been seen among adults with a long-term mental health condition – falling from 35.3% (in 2013 to 2014) to 26.8% (in 2018 to 2019) – prevalence remains substantially higher, despite the same levels of motivation to quit.

Now it is predicted that the Government is likely to miss its ‘Smokefree by 2030’ target. Projections undertaken by CRUK in Feb 2020 predicted that it will take until the mid-2040s to achieve smoking rates of less than 5% among the most deprived communities in England.


The UK health authorities have made multiple recommendations to provide additional support to specific groups of people who smoke. But despite this, rates of smoking in pregnant women hasn’t significantly gone down and smoking is still the biggest contributor to decreased life span in people with mental health conditions.

In 2019, in the UK:

  • Around 6.9 million people in the adult population still smoked.
  • 15.9% of men smoke compared with 12.5% of women.
  • Those aged 25 to 34 years had the highest proportion of current smokers (19.0%)

  

At the Centre for Health Research and Education (CHRE) we are passionate about preventive medicine. Our mantra is to ‘Bridge the policy and Practice Gap in healthcare’. In our smoking cessation work, we are product agnostic and do not favour any particular category of cessation tool.

To understand why there is a gap between UK’s policies and what is happening in practice, we needed to understand the challenges that the remaining smokers in UK are facing. To know these barriers, we conducted a quantitative research study on a sample of UK’s remaining smokers and their influencers, i.e. professionals who might have a positive influence on smoker’s quitting journey. This quantitative survey was preceded by qualitative research conducted by CHRE.

The ‘Smoke-free UK’ project was conducted to answer the question: ‘Who are the remaining ‘hard core’ of smokers in the UK and what are the drivers and barriers to quit among them?’

  

CHRE commissioned this site to openly and transparently share findings from the Smoke-free UK project with researchers.
We hope that this will facilitate the acceleration of UK’s journey in becoming smoke-free.

 


  

Funding declaration:

This project is conceptualised, designed, led and managed by the Centre for Health Research and Education (CHRE). CHRE applied for and was awarded a grant from the Foundation for a Smoke-Free World, Inc (FSFW) for a part of this project. The contents, selection, and presentation of facts, as well as any opinions expressed herein are the sole responsibility of the authors and under no circumstances shall be regarded as reflecting the positions of FSFW.

 


  

Publications, Presentations and Press Release from this Project

The findings from the qualitative and quantitative research phases of the project have huge implications on UK’s ambition to become smokefree by 2030. The COVID-19 pandemic, the related lockdowns and subsequent impact on the healthcare system as well as behaviours of smokers and ex-smokers cannot be underestimated. We presented our findings from this project in a pre-print publication on MedRxiv, accompanied it with a press release, and a global tobacco control conference presentation.